Skip to main content
INSM
NASDAQ Life Sciences

Insmed Lifts 2026 BRINSUPRI Guidance to $1.35–1.40B After $524.4M Q3

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$110.911
Mkt Cap
$24.369B
52W Low
$90.39
52W High
$212.75
52W Position info
23% above low
Off High info
48% below high
Rel. Volume info
3.9× avg
Market data snapshot near publication time

INSM sits 23% above its 52-week low of $90.39 on elevated volume (3.9× avg).

Summary

Insmed's Q3 revenue of $524.4M rose 268% year over year, with BRINSUPRI at $400.1M globally (up 29% sequentially) and ARIKAYCE at $124.4M. The net loss was $100.32M. The new information is the raised 2026 outlook: BRINSUPRI now $1.35–1.40B and ARIKAYCE $460–470M, following the August raise. The company held about $1.1B in cash, cash equivalents and marketable securities at September 30, 2026. On the pipeline, PALM-ILD Phase 3 is more than 35% enrolled with enrollment due H1 2028; PALM-PAH dosed its first patient in July 2026, PALM-PPF began in September 2026, and an IPF Phase 3 is planned for H1 2027. The FDA priority review for the ARIKAYCE label expansion carries a target action date in January 2027.

At the time of this announcement, INSM was trading at $110.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $24.4B. The 52-week trading range was $90.39 to $212.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

INSM - Latest Insights

INSM
Oct 29, 2026, 12:51 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $110.63
Real-time Price: $120.36 info
Change: +$9.73 (+9%) info
Market Cap: $26.404B info
INSM
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $120.36 info
Change: +$21.59 (+22%) info
Market Cap: $26.404B info
INSM
Oct 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $120.36 info
Change: +$21.59 (+22%) info
Market Cap: $26.404B info
INSM
Oct 15, 2026, 8:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $96.60
Real-time Price: $120.36 info
Change: +$23.76 (+25%) info
Market Cap: $26.404B info
INSM
Oct 05, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $112.63
Real-time Price: $120.36 info
Change: +$7.73 (+7%) info
Market Cap: $26.404B info